In a report released yesterday, Brandon Couillard from Jefferies reiterated a Hold rating on PerkinElmer (NYSE: PKI), with a price target of $82. The company’s shares closed yesterday at $86.55, close to its 52-week high of $86.96.
According to TipRanks.com, Couillard is a top 100 analyst with an average return of 28.2% and a 75.1% success rate. Couillard covers the Healthcare sector, focusing on stocks such as DENTSPLY SIRONA Inc, Organovo Holdings, and Exact Sciences.
Currently, the analyst consensus on PerkinElmer is a Moderate Buy with an average price target of $85.33, which is a -1.4% downside from current levels. In a report issued on August 1, Cowen & Co. also reiterated a Hold rating on the stock with a $85 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $86.96 and a one-year low of $62.43. Currently, PerkinElmer has an average volume of 606K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
PerkinElmer, Inc. (United States) engages in the provision of products, services, and solutions to diagnostics, food, environmental, industrial, life sciences research, and laboratory services markets. It operates through the Discovery and Analytical Solutions, and Diagnostics segments.
